Petros Grivas

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Petros Grivas
Mar 30, 2025, 10:05 | Blog
Chandler Park: MATOSGU25 meeting - A fun event with great camaraderie, engagement, and learning
Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared…
Mar 29, 2025, 18:49 | Blog
Sumanta K. Pal: Tremendous Names on the Fellows of ASCO List
Sumanta K. Pal, Vice Chair of Academic Affairs at City of Hope, shared a post…
Mar 25, 2025, 22:44 | Blog
Ishwaria Subbiah: Inspired by Dr. Robin Zon's commitment to engage with oncology state societies
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research…
Mar 17, 2025, 12:36 | Blog
Petros Grivas: Honored to serve as co-chair of ECOG-ACRIN Cancer Research Group GU committee
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Mar 4, 2025, 07:57 | Blog
Nicole D. Fleming: Fred Hutchinson Cancer Center Director’s Retreat
Fred Hutchinson Cancer Center recently convened its Director's Retreat, fostering discussions on strategic priorities and…
Feb 20, 2025, 09:43 | Insight
Neeraj Agarwal: No OS or PFS benefit with SG in pretreated mUC bladder cancer
Neeraj Agarwal, Presidential Endowed Chair of Cancer Research at  Huntsman Cancer Institute, shared a post…
Feb 16, 2025, 04:58 | Blog
Tom Powles: TROPICS4 - sacituzimab govitecan vs chemo in pretreated urothelial carcinoma
Tom Powles, Professor at the University of London, shared a post on X: "TROPICS4 sacituzimab…
Feb 13, 2025, 09:30 | Insight
Petros Grivas: TROPiCS04 P3 trial data has been published
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Feb 9, 2025, 14:15 | Blog
2025 Updates in Bladder and UT Cancers for Patients and their Loved Ones - Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center shared a post on X: "Join us on Saturday, March 1…
Feb 4, 2025, 17:28 | Insight
Karima Oualla: Proud of the 7th UroOncology Congress in Morocco
Karima Oualla, Professor of Medical Oncology at the Hassan II University Hospital, shared on LinkedIn:…
Feb 3, 2025, 15:23 | Blog
Petros Grivas: Amazing progress in biomarkers on bladder cancer
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Feb 3, 2025, 14:09 | Blog
Petros Grivas: Comprehensive talk by Marc-Olivier Timsit in surgery
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Feb 2, 2025, 01:51 | Blog
Shilpa Gupta: Great overview on PARPi and nuances of different agents at the GU Oncology meeting in Morocco
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X by…
Jan 29, 2025, 07:35 | Blog
Petros Grivas: Inspired after interacting with so awesome colleagues at AUC3
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Jan 27, 2025, 09:51 | Blog
Petros Grivas: Neoadjuvant Cisplatin-Based Chemotherapy + Peri-Operative Durvalumab as SOC in Fit Patients with MIBC
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Jan 25, 2025, 17:27 | Insight
Insights from AUC3 by Andrea Necchi
The Advanced Urologic Cancer Consensus Conference (AUC3) took place on January 23-24, 2025, at the…
Jan 25, 2025, 15:47 | Insight
Insights from AUC3 by Petros Grivas
The Advanced Urologic Cancer Consensus Conference (AUC3) took place on January 23-24, 2025, at the…
Jan 21, 2025, 15:32 | Science
Mohammad Jad Moussa: What drives post-surgical relapse in SCNEC of the Urinary Tract
Mohammad Jad Moussa, Oncology Fellow at MD Anderson Cancer Center, posted on X about recent…
Jan 21, 2025, 06:15 | Blog
Petros Grivas: Excited for our 12th Immune-related Adverse Events panel CME series
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Jan 17, 2025, 09:19 | Science
Petros Grivas: Genomic biomarkers and response/survival with anti-PD1/L1 in advanced Urothelial Carcinoma
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Jan 14, 2025, 07:59 | Science
Vadim Koshkin: Genomic Biomarkers Associated with EV Outcomes for Patients with Advanced Urothelial Carcinoma
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a recent article by…
Jan 11, 2025, 21:25 | Blog
Petros Grivas: My heart goes to people in the areas affected by the LA fires
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Jan 3, 2025, 21:19 | Insight
Advancements in urothelial carcinoma treatment - International Urology Cancer Summit
International Urology Cancer Summit shared a post on LinkedIn: "Advancements in urothelial carcinoma treatment. The latest…
Dec 28, 2024, 11:49 | Career
Petros Grivas: GU oncologist Position at Fred Hutchinson Cancer Center
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Dec 24, 2024, 14:29 | Drugs
Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma
Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology, shared a post on X: “Advanced urothelial carcinoma…
Dec 24, 2024, 07:56 | Science
Petros Grivas: Excited to see long term follow up of our IMvigor210 trial
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Dec 23, 2024, 13:06 | Blog
Omar Alhalabi: Analysis of UNITE Study Data
Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared on X: “Hot-off-press. Genomic…
Dec 19, 2024, 12:33 | Science
Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma - ESMO
ESMO posted on X about recent paper by Petros Grivas et al., titled "LBA9 TROPiCS-04,…
Dec 15, 2024, 03:39 | Insight
Petros Grivas: Phenomenal talk by Sumanta K. Pal on RCC
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Dec 8, 2024, 12:04 | Blog
Roberto Iacovelli: Tom Powles represented NIAGARA results for perioperative therapy of MIBC at ESMOAsia24
Roberto Iacovelli, Medical oncologist at Fondazione Policlinico Gemelli IRCCS in Rome, shared a post on…
Dec 8, 2024, 07:13 | Blog
Petros Grivas: Great to present TROPiCS04 trial at ESMOAsia24
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, reshared…
Dec 3, 2024, 11:48 | Blog
Petros Grivas: Kind reminder for active members to participate in ASCO election
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Dec 2, 2024, 17:57 | Blog
Petros Grivas: Ananya Choudhury on histology subtypes of Bladder Cancer
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Dec 1, 2024, 16:04 | Insight
Highlights from PROSCA 2024 by María Natalia Gandur Quiroga
PROSCA 2024, the final part of the RENALC-BLADDR-PROSCA 2024 forum, took place on November 29…
Nov 30, 2024, 23:26 | Blog
Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Nov 29, 2024, 15:54 | Insight
Highlights from BLADDR 2024 by María Natalia Gandur Quiroga
BLADDR 2o24, Second session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU Oncology,…
Nov 27, 2024, 16:55 | Insight
Highlights from RENALC 2024 by María Natalia Gandur Quiroga
RENALC 2o24, the opening session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU…
Nov 22, 2024, 16:40 | Blog
Voting in the ASCO Election is open until December 3
Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…
Nov 18, 2024, 15:58 | Insight
Petros Grivas: Fantastic experience to present at WA medical oncology society
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Nov 14, 2024, 14:09 | Blog
Vivek Subbiah: Supporting Dr. Petros Grivas for the Nominating Committee in the ASCO Election for 2025
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 12, 2024, 18:55 | Insight
María Natalia Gandur Quiroga: Just cast my vote for the ASCO election
María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…
Nov 12, 2024, 13:35 | Blog
Petros Grivas: Highlighting Advancement in Immunotherapy and cutting-edge clinical trial innovations
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…
Nov 11, 2024, 17:58 | Blog
COVID-19 Severity and Cancer Therapy
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a paper by Petros Grivas…
Nov 10, 2024, 15:02 | Insight
Petros Grivas - Candidate for ASCO Nominating Committee
Petros Grivas has been nominated as the Undesignated Member Candidate of the nomination committee for…
Nov 8, 2024, 19:30 | Blog
What’s next for combinatorial therapy in mUC - CEC Oncology
CEC Oncology shared a post on X: "What’s next for combinatorial therapy in mUC? Discover…
Nov 8, 2024, 14:46 | Blog
Dimitra R. Bakaloudi: Excited to see Petros Grivas among the ASCO nominated candidates
Dimitra R. Bakaloudi, Postdoctoral Hematology and Oncology Researcher in University of Washington, reshared a post…
Nov 7, 2024, 16:16 | Blog
Rohit Gosain: Excited to see these outstanding ASCO candidates
Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "It's crucial to…
Nov 5, 2024, 17:34 | Blog
Petros Grivas: Honored to be a candidate for ASCO nominating committee
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Nov 5, 2024, 16:30 | Blog
Pedro Barata: Thrilled to endorse Petros Grivas and Rana McKay for the ASCO Board Directors
Pedro Barata, Medical Oncologist at University Hospitals Seidman Cancer Center, posted on X: "I am…
Nov 3, 2024, 12:59 | Insight
Uromigos Live24 panel on novel ADCs in urothelial carcinoma
Uromigos shared a post on X: “Don't get spooked by new data - watch the…
Nov 2, 2024, 11:56 | Blog
Lefteris Mylonakis: Burnout, Depression, and Diminished Well-Being among Physicians
Lefteris Mylonakis posted on X: "Burnout, Depression, and Diminished Well-Being among Physicians High levels of…
Nov 2, 2024, 03:01 | Blog
Dimitra R. Bakaloudi: Sometimes the secret to success is simply finding your why
Dimitra R. Bakaloudi shared a post by Chandler Park on X, adding the following: “Sometimes the…
Nov 1, 2024, 19:20 | Blog
Chandler Park: Dr. Petros Grivas answers the most important question for junior faculty
Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared…
Oct 28, 2024, 13:09 | Insight
Petros Grivas: Stellar Faculty covering Genitourinary Cancers
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Oct 23, 2024, 11:45 | Blog
Carlos L. Arteaga: Honored to be elected to National Academy of Medicine
Carlos L. Arteaga, Director of the UT Southwestern Simmons Cancer Center, shared a post on…
Oct 23, 2024, 00:05 | Blog
Managing treatment-related adverse events in mUC - CEC Oncology
CEC Oncology shared a post on X: "Are you prepared to manage treatment-related adverse events…
Oct 21, 2024, 16:58 | Blog
NIAGARA study vs. dose-dense MVAC: Chandler Park's discussion with Petros Grivas
Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared…
Oct 12, 2024, 22:08 | Insight
Sumanta Pal: The 1st study to show an OS benefit with ARPI + PARP in mCRPC
Sumanta Pal shared a post on X: “Woke up to this incredible news from the…
Oct 11, 2024, 16:03 | Blog
Dimitra Rafailia Bakaloudi: The Uromigos trophy goes to TEAM USA
Dimitra Rafailia Bakaloudi shared a post on X: ''And the Uromigos trophy goes to TEAM…
Oct 10, 2024, 14:16 | Dialogues
NIAGARA Study Insights: Durvalumab and Chemotherapy in Bladder Cancer Treatment | Dr. Petros Grivas
In this episode of OncoDaily, Dr. Petros Grivas joins host Chandler Park to discuss the…
Oct 10, 2024, 12:54 | Dialogues
ESMO 2024 Highlights: OncoDaily Updates with Chandler Park on Cancer Breakthroughs
In episode three of OncoDaily, host Chandler Park welcomes Dr. Petros Grivas, a global leader…
Oct 7, 2024, 15:53 | Insight
Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma
Tres Uramigas shared on X: “Sure! Here’s the post without the usernames: AMBASSADOR: Phase III…
Oct 6, 2024, 17:01 | Blog
Petros Grivas: Jonathan Chou's amazing talk on bladder cancer surface biomarkers
Petros Grivas shared a post on X by Omar Mian, adding: "Fantastic to see Jonathan…
Oct 6, 2024, 12:55 | Blog
Rahul Gosain: GU Malignancy Highlights from ESMO24 with Petros Grivas
Rahul Gosain shared on LinkedIn: "GU Malignancy Highlights from ESMO24 with Petros Grivas: - NIAGARA…
Oct 5, 2024, 16:31 | Blog
Petros Grivas: Mentoring has become my passion
Petros Grivas shared a post on X: "My dad was such a dedicated teacher; he…
Oct 5, 2024, 16:19 | Blog
Enrique Grande: How many challenges in GU tumors to try to address in the upcoming years?
Petros Grivas shared a post on X: "Adding a few recent Grivas Selfie examples for friends…
Oct 5, 2024, 15:40 | Blog
Karima Oualla: Rich moments at MD Anderson Madrid
Karima Oualla shared a post on X: "Rich moments at MD Anderson Madrid with the great…
Oct 3, 2024, 13:00 | Positive
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
September was a significant month dedicated to raising awareness about various cancers, and Prostate Cancer…
Sep 24, 2024, 12:30 | Societies
11 ESMO24 presentations published on NEJM
At the 2024 ESMO Congress, 11 articles were presented that were published in NEJM, highlighting…
Sep 21, 2024, 14:16 | Blog
Sabine D. Brookman-May: The right questions addressed by Petros Grivas after NIAGARA trial presentation
Sabine D. Brookman-May shared a post by Roberto Iacovelli, on X, adding: ''The right questions…
Sep 20, 2024, 13:37 | Blog
Chandler Park: Outstanding discussion on the Niagara study by Petros Grivas
Chandler Park posted the following on X: “OUTSTANDING balanced discussion of the Niagara study by…
Sep 20, 2024, 11:51 | Blog
Zena Haddadin: Had the pleasure of meeting Petros Grivas at ESMO24
Zena Haddadin, MD at Jordan University of Science and Technology, shared a post on X:…
Sep 19, 2024, 14:05 | Blog
Yuksel Urun: The conference rooms are no longer enough for GU sessions at ESMO 24
Petros Grivas shared a post by Yuksel Urun on X: "Thrilled to co-chair GU session…
Sep 19, 2024, 08:59 | Insight
Fantastic talk by Toni Choueiri at ESMO2024 on Ti-Nivo2 trial
Petros Grivas shared a post by Yüksel Ürün on X, adding: "Fantastic talk by brilliant Toni Choueiri…
Sep 18, 2024, 14:14 | Blog
Petros Grivas: Ipilimumab/nivolumab vs standard care in non-clear cell renal cell cancer by Andrea Apolo
Petros Grivas shared a post by Andrea Apolo on X: "Agree with Andrea Apolo excellent…
Sep 17, 2024, 14:44 | Blog
Vivek Subbiah: Best oncology colleagues in the universe
  Petros Grivas shared a post by Vivek Subbiah on X, adding:   "Fantastic ESMO24.…
Sep 16, 2024, 16:18 | Societies
Key Findings from the NIAGARA Trial at ESMO 2024
The results of the NIAGARA trial were recently presented at ESMO 2024. The NIAGARA trial,…
Sep 15, 2024, 16:06 | Blog
Joaquim Bellmunt: The role of mTORC1/2 inhibitor sapanisertib
Petros Grivas shared an article by Joaquim Bellmunt on X: "Congrats Joaquim Bellmunt and your team…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 15:29 | Career
Omar Mian: Grateful for 8 wonderful years at the Cleveland Clinic
Omar Mian, Cancer Researcher and Radiation Oncologist at Fred Hutchinson Cancer Center, shared a post…
Sep 7, 2024, 15:45 | Blog
Dimitra R. Bakaloudi: Evaluating TMB and MSI in patients with Urothelial cancer treated with ICIs
Dimitra R. Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X about…
Sep 7, 2024, 14:51 | Blog
Petros Grivas about Perioperative treatment in MIBC at Libyan Association of Urology/Scientific Day
Petros Grivas shared a post by Refaat Abusamra, Chairman of Uro-oncology Section of Libyan Urological…
Sep 2, 2024, 15:01 | Insight
Liang Cheng: What’s the difference between urachal and nonurachal adenocarcinoma the bladder?
Liang Cheng shared on X: "What’s the difference between urachal and nonurachal adenocarcinoma the bladder?…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 31, 2024, 14:28 | Blog
Petros Grivas: Excited to present bladder cancer updates at Libya
Petros Grivas shared a post on X: "After Morocco and Uganda, am excited to present…
Aug 29, 2024, 16:36 | Blog
Highlights from IBCG24 Retreat
The International Bladder Cancer Group (IBCG) hosted a session at the American Urological Association (AUA)…
Aug 27, 2024, 19:10 | Blog
Petros Grivas: Looking forward to a fantastic ESMO24
Petros Grivas shared a post on X by ESMO, adding: "Looking forward to a fantastic…
Aug 26, 2024, 21:30 | Blog
Tian Zhang: 3 weeks til ESMO24!
Tian Zhang shared a post by ESMO on X, adding the following: “T -3 weeks…
Aug 25, 2024, 14:05 | Blog
Petros Grivas: Can’t wait for amazing Uromigos meeting!
Petros Grivas shared a post on X by Uromigos adding: "Can’t wait for amazing Uromigos…
Aug 24, 2024, 20:24 | Blog
Petros Grivas: Great to have dedicated colleagues in fight vs bladder cancer
Petros Grivas shared a post on X: "So excited to chat with rising superstar Karine Tawagi…
Aug 21, 2024, 04:28 | Societies
Registration is now open for the Masters in Therapeutic Oncology Summit – Genitourinary Edition
The Medical Educator Consortium (MEC) shared on LinkedIn: "Exciting News! Registration is NOW OPEN for…
Aug 15, 2024, 14:58 | Blog
MLS Seattle's updates in oncology from masters - The Medical Educator Consortium
The Medical Educator Consortium shared a post on X: “Save the Date! Join us on…
Aug 12, 2024, 13:28 | Positive
Pavlos Msaouel: The second Msaouel Lab R01 proposal has been funded to investigate Renal Medullary Carcinoma
Pavlos Msaouel, Physician-Scientist at Msaouel Lab, shared on X: "The second Msaouel Lab R01 proposal…
Aug 11, 2024, 19:06 | Insight
Shilpa Gupta: Amazing to meet Shailender Bhatia at BCANTT24
Shilpa Gupta shared on X: “Was amazing to meet Shailender Bhatia at BCANTT24 and learn from…
Aug 11, 2024, 15:57 | Blog
Petros Grivas: Phenomenal Bladder Cancer Advocacy Network
Petros Grivas shared a post a post on X by Shilpa Gupta: "Phenomenal Bladder Cancer…
Aug 10, 2024, 11:41 | Blog
Highlights from BCAN Bladder Cancer Think Tank Meeting 2024
The annual BCAN Bladder Cancer Think Tank Meeting is the premier annual bladder cancer-specific medical…
Aug 5, 2024, 16:49 | Insight
Petros Grivas: Stellar talk by Evan Hall on melanoma highlights from ASCO24
Petros Grivas shared on X: "Stellar talk by my fantastic colleague, Evan Hall (Fred Hutchinson…
Aug 5, 2024, 06:10 | Blog
Petros Grivas: From envisioning, via preparing to achieving
Petros Grivas shared a post on X: ''From envisioning, via preparing to achieving: Uromigos cup…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 3, 2024, 15:22 | Blog
Oncoinfluencers to Follow on Social Media: Dr Petros Grivas
We are excited to introduce Dr. Petros Grivas, a leading expert in genitourinary cancers, as…
12
All: 151 Posts: 1 - 100
Special Coverage